Parallax Volatility Advisers, L.P. - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.

Quarter-by-quarter ownership
Parallax Volatility Advisers, L.P. ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$4,410,250
+43.5%
162,500
+62.5%
0.01%
+42.9%
Q2 2023$3,074,000
+288.9%
100,000
+400.0%
0.01%
+600.0%
Q4 2022$790,400
-1.7%
20,0000.0%0.00%0.0%
Q3 2022$804,000
-88.8%
20,000
-88.9%
0.00%
-83.3%
Q4 2021$7,173,000
-13.8%
180,000
-21.8%
0.01%0.0%
Q3 2021$8,319,000
+304.2%
230,200
+358.6%
0.01%
+200.0%
Q2 2021$2,058,000
-6.7%
50,200
-0.7%
0.00%0.0%
Q1 2021$2,205,000
+5.0%
50,543
+16.8%
0.00%0.0%
Q2 2020$2,101,00043,2760.00%
Other shareholders
ROYALTY PHARMA PLC shareholders Q3 2023
NameSharesValueWeighting ↓
Siguler Guff Advisers, LLC 3,391,754$92,052,20447.04%
Indie Asset Partners, LLC 433,000$11,751,62011.84%
SUVRETTA CAPITAL MANAGEMENT, LLC 4,095,745$111,158,5196.01%
Advanced Portfolio Management, LLC 230,000$6,242,2005.25%
Compound Global Advisors, LLC 626,412$17,000,8223.73%
Geo Capital Gestora de Recursos Ltd 135,079$3,6663.39%
TORRAY INVESTMENT PARTNERS LLC 412,633$11,198,8601.98%
Overbrook Management Corp 298,712$8,107,0441.89%
Silicon Valley Community Foundation 358,270$9,723,4481.18%
Greytown Advisors Inc. 74,601$2,024,6711.12%
View complete list of ROYALTY PHARMA PLC shareholders